Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group. (Q53398188)
Jump to navigation
Jump to search
scientific article published in January 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group. |
scientific article published in January 2003 |
Statements
Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group. (English)
G Fountzilas
A Bamias
G Aravantinos
C Kalofonos
N Timotheadou
V Siafaka
I Vlahou
D Janinis
D Pectasides
N Pavlidis
Hellenic Cooperative Oncology Group
1 January 2003
64
2
102-110